- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 239/78 - QuinazolinesHydrogenated quinazolines with hetero atoms directly attached in position 2
Patent holdings for IPC class C07D 239/78
Total number of patents in this class: 64
10-year publication summary
|
8
|
3
|
6
|
2
|
4
|
10
|
4
|
3
|
2
|
0
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Shanghai Yingli Pharmaceutical Co., Ltd. | 43 |
5 |
| Dana-Farber Cancer Institute, Inc. | 2571 |
4 |
| Gilead Sciences, Inc. | 2036 |
4 |
| Guangzhou Maxinovel Pharmaceuticals Co., Ltd. | 34 |
4 |
| Merck Sharp & Dohme Corp. | 2194 |
2 |
| Centre National de La Recherche Scientifique | 10418 |
2 |
| Bayer Cropscience AG | 2035 |
2 |
| Commissariat à l'énergie atomique et aux energies alternatives | 10923 |
2 |
| Association Francaise Contre Les Myopathies | 119 |
2 |
| Association Institut de Myologie | 114 |
2 |
| Auspex Pharmaceuticals, Inc. | 186 |
2 |
| Emory University | 1626 |
2 |
| Forschungszentrum Julich GmbH | 611 |
2 |
| Institut National de La Sante et de La Recherche Medicale (inserm) | 2822 |
2 |
| Yale University | 2378 |
2 |
| Sorbonne Universite | 1279 |
2 |
| Université Paris-saclay | 535 |
2 |
| The Regents of the University of California | 19918 |
1 |
| Pfizer Inc. | 3387 |
1 |
| The Regents of the University of Michigan | 4698 |
1 |
| Other owners | 18 |